Back to Journals » Hepatic Medicine: Evidence and Research » Volume 9

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

Total article views   HTML views PDF downloads Totals
9,070 Dovepress* 7,838+ 1,167 9,005
PubMed Central* 1,232 191 1,423
Totals 9,070 1,358 10,428
*Since 25 September 2017

View citations on PubMed Central and Google Scholar